Juvenescence Ltd 13D and 13G filings for AgeX Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-09 4:45 pm Purchase | 2024-11-27 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 4,530,374 42.000% | 1,000,000 (+28.33%) | Filing |
| 2024-07-05 4:01 pm Purchase | 2024-06-06 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 3,530,374 38.000% | 862,917 (+32.35%) | Filing |
| 2024-03-26 4:03 pm Purchase | 2024-03-20 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 2,667,457 81.400% | 40,224 (+1.53%) | Filing |
| 2024-03-07 07:47 am Purchase | 2024-03-05 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 2,627,233 81.100% | 26,338 (+1.01%) | Filing |
| 2024-02-14 4:01 pm Purchase | 2024-02-13 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 2,600,895 81.000% | 61,564 (+2.42%) | Filing |
| 2024-02-05 07:19 am Purchase | 2024-02-01 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 2,539,331 80.600% | 23,320 (+0.93%) | Filing |
| 2024-01-17 4:19 pm Purchase | 2024-01-16 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 2,516,011 80.400% | 44,421 (+1.80%) | Filing |
| 2024-01-09 4:16 pm Sale | 2024-01-03 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 2,471,590 80.200% | -39,414 (-1.57%) | Filing |
| 2023-12-13 5:11 pm Purchase | 2023-12-05 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 2,511,004 80.400% | 159,399 (+6.78%) | Filing |
| 2023-11-16 4:01 pm Purchase | 2023-11-15 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 2,351,605 79.400% | 20,191 (+0.87%) | Filing |
| 2023-11-01 4:28 pm Purchase | 2023-08-22 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 2,331,414 79.200% | 80,037 (+3.56%) | Filing |
| 2023-08-24 4:48 pm Sale | 2023-07-21 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 2,251,377 78.600% | -14,730 (-0.65%) | Filing |
| 2023-04-12 4:05 pm Purchase | 2023-04-04 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 2,266,107 78.800% | 7,785 (+0.34%) | Filing |
| 2023-03-22 4:16 pm Purchase | 2023-03-15 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 2,258,321 78.700% | 363,179 (+19.16%) | Filing |
| 2023-02-17 07:01 am Purchase | 2023-02-15 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 1,895,142 75.600% | 272,128 (+16.77%) | Filing |
| 2023-01-27 4:01 pm Sale | 2023-01-25 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 1,623,014 72.600% | -202,333 (-11.08%) | Filing |
| 2022-12-15 4:06 pm Purchase | 2022-12-14 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 1,825,347 74.900% | 135,299 (+8.01%) | Filing |
| 2022-10-25 4:05 pm Purchase | 2022-10-21 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 1,690,048 73.400% | 110,763 (+7.01%) | Filing |
| 2022-08-23 4:11 pm Sale | 2022-08-16 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 1,579,285 72.100% | -29,339 (-1.82%) | Filing |
| 2022-06-24 4:17 pm Purchase | 2022-06-06 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 1,608,624 72.500% | 304,289 (+23.33%) | Filing |